AMBU A/S – Trademark Portfolio
Entity Type: 03
AMBU A/S holds 64 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 61 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 5 Nice Classification classes. Currently, 38 trademarks are registered. Notable registered marks include AMBU, SPUR, ACART, AVIEW, and ASCOPE. The owner is based in BALLERUP.
BALTORPBAKKEN 13
BALLERUP DK-2750 , DK
Showing of trademarks Trademarks
Trademark Classifications
AMBU A/S's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does AMBU A/S have?
AMBU A/S has 64 U.S. trademarks filed with the USPTO. Of these, 38 registered, 10 abandoned, 13 cancelled.
What trademark classes does AMBU A/S file in?
AMBU A/S files trademarks across 5 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are AMBU A/S's most well-known trademarks?
AMBU A/S's registered trademark portfolio includes well-known marks such as AMBU, SPUR, ACART, AVIEW, and ASCOPE. These are among 38 currently registered trademarks in the portfolio.
What is AMBU A/S's trademark registration success rate?
AMBU A/S has a 62% trademark registration rate, with 38 out of 61 resolved applications resulting in successful registration. Currently, 0 applications are pending review.